Heat labile enterotoxin of E. coli: A potential adjuvant for transcutaneous cancer immunotherapy

Vaccine

Volumn 24, Issue 5, 2006, Pages 636-643

  Pitcovski, J ^a   Bazak, Z ^b   Wasserman, Elena ^a   Elias, Orit ^b   Levy, Adva ^a   Peretz, Tamar ^b   Fingerut, Elena ^a   Frankenburg, Shoshana ^b  

^a Hadassah Medical Organization ^*

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Heat labile enterotoxin; Immunotherapy; Skin

Indexed keywords

ANTIBODY; ESCHERICHIA COLI ENTEROTOXIN; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN GP 100; MELANOMA ANTIGEN; POLYPEPTIDE; TUMOR ANTIGEN;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; GENE FUSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKIN;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; BACTERIAL TOXINS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DRUG CARRIERS; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-12; MELANOMA; MICE; MOLECULAR SEQUENCE DATA; MONOCYTES; NEOPLASMS; PEROXIDASE; SKIN;

EID: 29544438516     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.052     Document Type: Article

References (31)

1. S.A. Hammond, D. Walwender, C.R. Alving, and G.M. Glenn Transcutaneous immunization: T cell responses and boosting of existing immunity Vaccine 19 2001 2701 2707
2. V. Cerundolo, I.F. Hermans, and M. Salio Dendritic cells: a journey from laboratory to clinic Nat Immunol 5 2004 7 10
3. K.L. Kotloff, M.B. Sztein, S.S. Wasserman, G.A. Losonsky, S.C. DiLorenzo, and R.I. Walker Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection Infect Immun 69 2001 3581 3590
4. J.A. Neidleman, M. Vajdy, M. Ugozzoli, G. Ott, and D. O'Hagan Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55 Immunology 101 2000 154 160
5. C.P. Simmons, T. Hussell, T. Sparer, G. Walzl, P. Openshaw, and G. Dougan Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses J Immunol 166 2001 1106 1113
6. T. Scharton-Kersten, G.M. Glenn, R. Vassell, J. Yu, D. Walwender, and C.R. Alving Principles of transcutaneous immunization using cholera toxin as an adjuvant Vaccine 17 Suppl. 2 1999 S37 S43
7. A.S. Beignon, J.P. Briand, R. Rappuoli, S. Muller, and C.D. Partidos The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin Infect Immun 70 2002 3012 3019
8. T. Yamamoto, T. Tamura, and T. Yokota Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans J Biol Chem 259 1984 5037 5044
9. N. Lucke, T. Tsuji, and J. Holmgren The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxin is linked to their ADP-ribosyltransferase activity Eur J Immunol 22 1992 2277 2281
10. I.K. Feil, R. Reddy, L. de Haan, E.A. Merritt, F. van den Akker, and D.R. Storm Protein engineering studies of A-chain loop 47-56 of Escherichia coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicity Mol Microbiol 20 1996 823 832
11. B.L. Dickinson, and J.D. Clements Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity Infect Immun 63 1995 1617 1623
12. N.A. Williams Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic Int J Med Microbiol 290 2000 447 453
13. C.V. Harding Class II antigen processing: analysis of compartments and functions Crit Rev Immunol 16 1996 13 29
14. S. Raychaudhuri, and K.L. Rock Fully mobilizing host defense: building better vaccines Nat Biotechnol 16 1998 1025 1031
15. L. De Haan, A.R. Hearn, A.J. Rivett, and T.R. Hirst Enhanced delivery of exogenous peptides into the Class I antigen processing and presentation pathway Infect Immun 70 2002 3249 3258
16. L. Petrovska, L. Lopes, C.P. Simmons, M. Pizza, G. Dougan, and B.M. Chain Modulation of dendritic cell endocytosis and antigen processing pathways by Escherichia coli heat-labile enterotoxin and mutant derivatives Vaccine 21 2003 1445 1454
17. J. Buereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
18. G.M. Glenn, D.N. Taylor, X. Li, S. Frankel, A. Montemarano, and C.R. Alving Transcutaneous immunization: a human vaccine delivery strategy using a patch Nat Med 6 2000 1403 1406
19. F. Guerena-Burgueno, E.R. Hall, D.N. Taylor, F.J. Cassels, D.A. Scott, and M.K. Wolf Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously Infect Immun 70 2002 1874 1880
20. A.W. Butch, K.A. Kelly, and N.C. Munshi Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein Exp Hematol 29 2001 85 92
21. E. Fingerut, B. Gutter, R. Meir, D. Eliahoo, and J. Pitcovski Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast Vaccine 23 2005 4685 4696
22. Y. Altuvia, and H. Margalit Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism J Mol Biol 295 2000 879 890
23. S. Frankenburg, O. Elias, Y. Gelbart, O. Drize, M. Lotem, and A. Ingber Recombinant hydrophilic human gp100: uptake by dendritic cells and stimulation of autologous CD8+ lymphocytes from melanoma patients Immunol Lett 94 2004 253 259
24. Y. Gelbart, S. Frankenburg, Y. Pinchasov, S. Krispel, D. Eliahu, and O. Drize Production and purification of melanoma gp100 antigen and polyclonal antibodies Protein Exp Purif 34 2004 183 189
25. N. Haicheur, E. Bismuth, S. Bosset, O. Adotevi, G. Warnier, and V. Lacabanne The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens J Immunol 165 2000 3301 3308
26. K.W. Ong, A.D. Wilson, T.R. Hirst, and A.J. Morgan The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines J Virol 77 2003 4298 4305
27. M. Guebre-Xabier, S.A. Hammond, D.E. Epperson, J. Yu, L. Ellingsworth, and G.M. Glenn Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells J Virol 77 2003 5218 5225
28. S.A. Fraser, L. de Haan, A.R. Hearn, H.K. Bone, R.J. Salmond, and A.J. Rivett Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions Infect Immun 71 2003 1527 1537
29. M.C. Gagliardi, F. Sallusto, M. Marinaro, A. Langenkamp, A. Lanzavecchia, and M.T. De Magistris Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming Eur J Immunol 30 2000 2394 2403
30. F. Anjuere, A. George-Chandy, F. Audant, D. Rousseau, J. Holmgren, and C. Czerkinsky Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses J Immunol 170 2003 1586 1592
31. J. Pitcovski, B. Gutter, G. Gallili, M. Goldway, B. Perelman, and G. Gross Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens Vaccine 21 2003 4736 4743